Nuance Medical has launched HurriCaine ONE 4% Lidocaine, a unit-dose topical anesthetic designed to provide rapid pain relief while supporting infection prevention initiatives. The fast-acting, non-aerosol spray delivers topical anesthesia within approximately 5 minutes and can be used for venipuncture, IV starts, vaccinations, port access, PICC line procedures, and other minor external procedures. Single-patient-use packaging helps reduce the risk of cross-contamination, while CHG compatibility allows seamless integration into existing skin preparation protocols. HurriCaine ONE Lidocaine is designed to combine targeted pain management with workflow efficiency, helping to improve the patient experience while supporting safe, hygienic clinical practices.